A five-year study suggests gene therapy may help reduce bleeding and infusions as a hemophilia B treatment option.

Researchers are closing in on a new kind of protection against the deadliest drug in the United States: a vaccine that trains the immune system to trap fentanyl before it reaches the brain. If early ...

A novel experimental vaccine against the nipah virus has succeeded in its first major test in humans; it has been shown to be ...

Flu activity has surged in many parts of the Northern Hemisphere, driven primarily by a newly emerged H3N2 strain known as ...

Researchers used AI to identify an mpox protein that triggers a strong immune response in mouse models. | Drug Discovery And ...

NEW HAVEN, Conn., Dec. 23, 2025 (GLOBE NEWSWIRE) -- Invivyd, Inc. (Nasdaq: IVVD) today announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation for VYD2311, an ...

DECLARATION is a Phase 3, randomized, placebo-controlled clinical trial to evaluate the safety and efficacy of VYD2311 in the prevention of COVID ...

Vaccines that display filovirus surface proteins on engineered, self-assembling protein nanoparticles improve immune system detection of the virus.

The study evaluated GEO-CM04S1 in the K18-hACE2 lethal mouse model, comparing immune responses and efficacy to experimental MVA-vectored vaccine constructs expressing spike alone (S) or nucleocapsid ...

A novel AI model helped find a key protein, named OPG153, in monkeypox virus, which could lead to cheaper and simple vaccine or a new antibody drug design.

Invivyd expects to present in vitro VBY329 data at a future medical congress. Invivyd is moving VBY329 into IND-enabling processes with a goal of IND readiness in the second half of 2026.

Scientists have used antibodies from a human donor with a self-induced hyper-immunity to snake venom to develop what they claim is the most broadly effective antivenom cocktail to date. Their ...